Hope Hp‐GC Project—Program Implementation for Primary and Secondary Prevention of Gastric Cancer in Latin America
- 1 March 2026
- journal article
- research article
- Published by Wiley in Helicobacter
- Vol. 31 (2) , e70109
Abstract
Introduction: Gastric cancer (GC) is the fifth leading cause of cancer‐related mortality globally; its main burden is concentrated in East Asia and some areas of Europe and Latin America. This study aims to develop an organized and structured GC prevention pilot program in intermediate‐to‐high‐incidence countries in Latin America. Methods: This study involved two strategies: (a) primary prevention for screen‐and‐treat H. pylori infection among individuals aged 30–39 years ( n = 7500, 500 in 15 sites), and (b) primary and secondary prevention for individuals aged 40–75 years ( n = 9600, 600 in 16 sites) with tiered risk stratification using an algorithm developed and validated in Chile (Gastrocalc: priority 1 to 6; age, sex, hypertension, IgG H. pylori , pepsinogen I and II, and Gastrin‐17b), and high‐quality esophagogastroduodenoscopy (EGD) evaluation. Results: Pilot phases were successfully conducted in Chile and Colombia during 2023–2025. In Chile (Molina), 4152 asymptomatic individuals were tested with H. pylori prevalence of 46% ( n = 113/246) in 2023, 34% ( n = 504/1484) in 2024, and 32% ( n = 609/1904) in 2025. The H. pylori prevalence among individuals aged 30–39 years (592/4152; 14.3%) was 37.8%. In Colombia, 1250 asymptomatic individuals were screened across four regions; in 2025, the prevalence of H. pylori among individuals aged 30–39 years was 69% ( n = 895/1250). The validation of Gastrocalc included 866 individuals from 5 regions in Chile. The algorithm successfully identified 80.6% of OLGA III–IV patients and 100% of GC patients (Priority 1–4). Other countries will start activities in 2026. Conclusions: This pioneering study will advance understanding and feasibility of urgently needed primary and secondary prevention for GC in Latin America.Keywords
This publication has 32 references indexed in Scilit:
- Population-level cancer screening and cancer care in Bhutan, 2020–2023: a reviewThe Lancet Regional Health - Southeast Asia, 2024
- AGA Clinical Practice Update on High-Quality Upper Endoscopy: Expert ReviewClinical Gastroenterology and Hepatology, 2024
- Recommendations for gastric cancer prevention and control in the AmericasThe Lancet Regional Health - Americas, 2023
- Implementation of the updated Sydney system biopsy protocol improves the diagnostic yield of gastric preneoplastic conditions: Results from a real-world studyGastroenterología y Hepatología, 2023
- Tu1129 COMBINATION OF LOW-COST SERUM BIOMARKERS YIELD EXCELLENT PREDICTIVE PERFORMANCE FOR THE NON-INVASIVE DETECTION OF GASTRIC NEOPLASIAGastroenterology, 2023
- Cost-effectiveness of prevention and early detection of gastric cancer in Western countriesBest Practice & Research Clinical Gastroenterology, 2021
- Global burden of cancer attributable to infections in 2018: a worldwide incidence analysisThe Lancet Global Health, 2020
- Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countriesThe Lancet, 2018
- The significance of OLGA and OLGIM staging systems in the risk assessment of gastric cancer: a systematic review and meta-analysisGastric Cancer, 2018
- Risk of Recurrent Helicobacter pylori Infection 1 Year After Initial Eradication Therapy in 7 Latin American CommunitiesJAMA, 2013